ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
pdf
Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease [Anatol J Cardiol]
Anatol J Cardiol. 2023; 27(1): 54-55 | DOI: 10.14744/AnatolJCardiol.2022.2333

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease

Anetta Undas
Department of Thromboembolic Diseases, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland; Center for Research and Innovative Technology John Paul II Hospital, Kraków, Poland

Anetta Undas. Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease. Anatol J Cardiol. 2023; 27(1): 54-55

Corresponding Author: Anetta Undas
Manuscript Language: English
TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search



  1. Home
  2. About
  3. Abstrating and Indexing
  1. Copyright
  2. Aim and Scope
  3. Editorial Board
  1. Instructions for Authors
  2. ICMJE Recommendations
  3. Contact

Copyright © 2023 The Anatolian Journal of Cardiology



LookUs  &   Online Makale